Astal Laboratories Ltd Fair Value
ASTALLTD · Commercial Services · Current price ₹77
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹138 | 25% ROE fading to 12% over ~10 yrs, on ₹78 book |
| Relative P/E | ₹85 | EPS × 30.3 peer-median P/E |
| Graham floor | ₹70 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Astal Laboratories Ltd undervalued?
DocStoX estimates the fair value of Astal Laboratories Ltd at ₹112 per share, versus the current market price of ₹77. That puts the stock about +46.1% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹138), Relative P/E (₹85), Graham floor (₹70). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹70 (bear) to ₹112 (base) to ₹138 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Astal Laboratories Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.